News & Updates

2026-07-10

DDA Conference Is About to Begin — Hotgen Biotech to Showcase Its Complete IVD Solutions in India

2026-06-10

Consensus Interpretation | The Value of Cytokine Testing in Immune-Mediated Inflammatory Diseases

2026-05-24

Authoritative Research Reveals: MASLD Is Becoming the Primary "Culprit" of Liver Cancer

2026-05-18

Inheriting the Bethune Spirit, Empowering New Development in Laboratory Medicine | Hotgen Biotech Shines at the 2026 Bethune Laboratory Medicine Conference

2026-05-15

Standardized MASLD Management in Japan: Non-Invasive Diagnosis and Treatment Experience Centered on CK-18

2026-04-20

Breaking News! The Fatty Liver Duo (CK18-M30/M65) Included in the "Standard for MAFLD Tiered Diagnosis and Treatment & Standardized Management Center Construction" — Hotgen Biotech Helps Bring the Standard to Practice

2026-04-13

Liwan District, Guangdong Launches Community-Based Liver Cancer Early Screening Pilot, Exploring the "Liwan Model" for Non-Cirrhotic Populations

2026-04-07

In-Depth Interpretation of the Guideline for Osteoporosis Screening and Health Management in the Physical Examination Population (2026)

2026-03-23

Four Major Highlights at CACLP: Whole-Blood Chemiluminescence C2100, AI Automation Line, Small Molecules, and the Fatty Liver Duo — Hotgen Biotech Wins Market Opportunities with Innovation Speed

2026-03-10

You're Invited! "Facing the Sea, Setting Sail on the Waves" New Product Launch — Hotgen Biotech Invites You to Witness Innovation @CACLP 2026

2026-03-06

2026 Two Sessions Health Forum | Fatty Liver Screening Enters the Era of Precision Testing